You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Quantum Molecular Resonance

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dry Eye Trial in Gallarate (Rexon-Eye)

Completed
  • Dry Eye
  • Rexon-Eye
  • Gallarate, VA, Italy
    Centro Oculistico Borroni
Nov 3, 2023

Dry Eye Syndromes Trial in Tel Aviv (Rexon device)

Recruiting
  • Dry Eye Syndromes
  • Rexon device
  • Tel Aviv, Israel
    Shamir Medical Center
Jul 19, 2022

Meibomian Gland Dysfunction Trial in Bangkok (Rexon-eye)

Recruiting
  • Meibomian Gland Dysfunction
  • Rexon-eye
  • Bangkok, Thailand
    Chulalongkorn University
Dec 7, 2021

Glioma, Malignant, Computer-Assisted Surgery Trial in Shanghai

Active, not recruiting
  • Glioma, Malignant
  • Computer-Assisted Surgery
    • Shanghai, Shanghai, China
      Fudan University
    Dec 16, 2022

    MRI Radiomics Combined With Pathomics on Prediction of Molecular

    Not yet recruiting
    • Endometrial Neoplasms
    • next generation sequencing AND Immunohistochemical examination
    • Fuzhou, Fujian, China
      Clinical Oncology School of Fujian Medical University, Fujian Ca
    Nov 13, 2023

    Kidney Tumors Trial in Taoyuan (multiparametric and fat-detection magnetic resonance imaging (MRI))

    Active, not recruiting
    • Kidney Neoplasms
    • multiparametric and fat-detection magnetic resonance imaging (MRI)
    • Taoyuan, Taiwan
      Li-Jen Wang
    Nov 9, 2023

    Aging, Aging Well Trial (In-home resonance-based electromagnetic field protection device)

    Not yet recruiting
    • Aging
    • Aging Well
    • In-home resonance-based electromagnetic field protection device
    • (no location specified)
    Mar 10, 2022

    Glioma Trial in London (Advanced MRI sequences)

    Not yet recruiting
    • Glioma
    • Advanced MRI sequences
    • London, United Kingdom
      King's R&I department
    Feb 22, 2022

    Lung Carcinoma Metastatic in the Brain, Stage IV Lung Non-Small Cell Cancer AJCC v7 Trial in Portland (drug, other, procedure,

    Terminated
    Has Results
    • Lung Carcinoma Metastatic in the Brain
    • Stage IV Lung Non-Small Cell Cancer AJCC v7
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Jul 14, 2022

    Glioma, Brain Tumor, Primary Brain Tumor Trial in Miami (3T MRI Scanner)

    Recruiting
    • Glioma
    • +4 more
    • 3T MRI Scanner
    • Miami, Florida
      University of Miami
    Mar 15, 2022

    Rhabdomyosarcoma, Non-Rhabdo. Soft Tissue Sarcoma Trial in Toronto (18F-FAZA (F18-Fluoroazomycin Arabinoside), Blood Oxygen

    Enrolling by invitation
    • Rhabdomyosarcoma
    • Non-Rhabdo. Soft Tissue Sarcoma
    • 18F-FAZA (F18-Fluoroazomycin Arabinoside)
    • +3 more
    • Toronto, Ontario, Canada
      The Hospital for Sick Children
    Nov 24, 2021

    Spinal Stenosis, Lumbar Region, With Neurogenic Claudication Trial in Madrid (Epiduroscopy)

    Recruiting
    • Spinal Stenosis, Lumbar Region, With Neurogenic Claudication
    • Epiduroscopy
    • Madrid, Spain
      Unidad de Investigación Clínica Secretaría Técnica CEImFJD Hospi
    Oct 14, 2021

    Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor Negative Trial in United States (procedure, other,

    Active, not recruiting
    • Estrogen Receptor Negative
    • +3 more
    • Dynamic Contrast-Enhanced Magnetic Resonance Imaging
    • +3 more
    • Houston, Texas
    • +5 more
    Feb 11, 2022

    MRI With PET / CT in Evaluation of Response to Neoadjuvant

    Completed
    • Breast Cancer
    • Chemotherapy Effect
    • Istanbul, Kadikoy, Turkey
      Istanbul Medeniyet University Goztepe City Hospital
    May 8, 2021

    Advanced Malignant Solid Tumor, Locally Advanced Malignant Solid Tumor Trial (drug, procedure, biological)

    Not yet recruiting
    • Advanced Malignant Solid Neoplasm
    • Locally Advanced Malignant Solid Neoplasm
    • (no location specified)
    Dec 2, 2022

    Dry Eye Trial in Singapore (Rexon-eye)

    Recruiting
    • Dry Eye
    • Rexon-eye
    • Singapore, Singapore
      Singapore Eye Research Institute
    Sep 21, 2021

    BCLC Stage A Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma Trial in

    Recruiting
    • BCLC Stage A Hepatocellular Carcinoma
    • +3 more
    • 18F-Fluoromisonidazole
    • +3 more
    • Atlanta, Georgia
      Emory University Hospital/Winship Cancer Institute
    May 25, 2022

    Glioma Trial in Shenyang (Magnetic Resonance Elastography, Assessment and Recording)

    Recruiting
    • Glioma
    • Magnetic Resonance Elastography
    • Assessment and Recording
    • Shenyang, Liaoning, China
      Shengjing Hospital
    Aug 6, 2023

    Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v7 Trial in Atlanta (CT

    Active, not recruiting
    • Castration-Resistant Prostate Carcinoma
    • +2 more
    • CT (Computed Tomography)
    • +2 more
    • Atlanta, Georgia
      Emory University Hospital/Winship Cancer Institute
    Mar 3, 2022

    Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer Trial in Algeria, Jordan, Saudi Arabia (Combination of

    Not yet recruiting
    • Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer
    • Combination of Palbociclib and aromatase inhibitor (Letrozole or Anastrozole)
    • Blida, Algeria
    • +6 more
    Dec 28, 2021

    Clinical, patHOlogical and Imaging Project of nEuro-oncology

    Recruiting
    • Glioma
    • This study does not intervene in this process.
    • Beijing, Beijing, China
      Beijing Tiantan Hospital
    May 16, 2023

    Glioma, Malignant Trial in Rom, Rome (histopathological analysis; morphological and non-morphological magnetic resonance)

    Completed
    • Glioma, Malignant
    • histopathological analysis; morphological and non-morphological magnetic resonance
    • Rom, Roma, Italy
    • +1 more
    Mar 28, 2023

    Retinitis Pigmentosa Trial (2C-QD, Sham 2C-QD)

    Not yet recruiting
    • Retinitis Pigmentosa
    • 2C-QD
    • (no location specified)
    Apr 24, 2023

    Extramedullary Myeloma Trial in Melbourne (Combination Product: JNJ-68284528 (Cilta-cel) & 64Cu SPION dual PET-MR imaging agent)

    Not yet recruiting
    • Extramedullary Myeloma
    • Combination Product: JNJ-68284528 (Cilta-cel) & 64Cu SPION dual PET-MR imaging agent
    • Melbourne, Victoria, Australia
      Peter MacCallum Cancer Centre
    Dec 18, 2022

    Breast Carcinoma, Colon Carcinoma, Esophageal Carcinoma Trial in Los Angeles (Computed Tomography, Gallium Ga 68 FAPi-46,

    Recruiting
    • Breast Carcinoma
    • +10 more
    • Computed Tomography
    • +4 more
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    Nov 29, 2022